AntiCoagAF 與 dark GCS 使用情況與統計

This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF). It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban. Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information. Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
  • Apple App Store
  • 付費
  • 醫療

商店排名

- -

The Glasgow Coma Scale (GCS) was developed in 1974 to assess the depth of impaired consciousness and coma following trauma. There have been a few tweaks to the GCS over the past 40 years as well as some clarification in testing. Also includes pediatric GCS (for ages 2 and younger).
  • Apple App Store
  • 付費
  • 醫療

商店排名

- -

AntiCoagAF與 dark GCS 比較排名

比較過去 28 天的 AntiCoagAF 排名趨勢與 dark GCS

排名

無可用數據

各國 AntiCoagAF vs. dark GCS 排名比較

比較過去 28 天的 AntiCoagAF 排名趨勢與 dark GCS

所有類別

無可用數據

醫療

應用程式
頂級國家
排名
- -
- -
#58

使用我們的免費試用版,與所有網站進行比較

立即開始
AntiCoagAF VS.
dark GCS

1月 1, 2025